SANA Q3 2024 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$62M

Net Income

-$60M

EPS (Diluted)

$-0.25

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$56M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$559M

Total Liabilities

$267M

Stockholders' Equity

$292M

Cash & Equivalents

$127M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$62M	-$2M	-2731.8%
Net Income	-$60M	$984,000	-6189.8%